WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information.
Adverse event
Clinical trial
Drug coding
Patient safety
Pharmacovigilance
Standardised Drug Groupings (SDG)
Journal
Therapeutic innovation & regulatory science
ISSN: 2168-4804
Titre abrégé: Ther Innov Regul Sci
Pays: Switzerland
ID NLM: 101597411
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
23
12
2019
accepted:
09
02
2020
pubmed:
23
2
2020
medline:
3
6
2021
entrez:
21
2
2020
Statut:
ppublish
Résumé
The WHODrug medicinal information dictionary is a worldwide source of global medicinal information with the aim to facilitate the coding of medications in clinical trials as well as identification of medication-related problems when monitoring patient safety, thereby supporting the development and usage of effective and safe medications. WHODrug contains individual trade names, active ingredients and additional information such as marketing authorisation holder, country of sale, pharmaceutical form and strength. All related medications are linked using a structured WHODrug alphanumeric code, connecting trade names and variation of the ingredient with the active moiety of the ingredient. Medications in WHODrug are classified using the ATC system and clustered into Standardised Drug Groupings, to allow for grouping of medications with one or more properties in common. The built-in data structure and the classification of medications in WHODrug facilitate various ways of aggregating medications for identification and analysis of possible adverse drug reactions. The different information levels in WHODrug are used to explore the relationship between a medication or a class of medications and an adverse event. By using WHODrug in clinical trials and post-marketing safety, accurate and standardised medication information can be achieved globally and allow easy information exchange. To meet the demands of WHODrug users from the pharmaceutical industry, academia and regulatory authorities, it is relevant to keep the dictionary comprehensive, validated and constantly updated on a global scale.
Identifiants
pubmed: 32078733
doi: 10.1007/s43441-020-00130-6
pii: 10.1007/s43441-020-00130-6
pmc: PMC7458889
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1116-1122Références
Br J Clin Pharmacol. 2018 Aug;84(8):1858-1859
pubmed: 29797731
Perspect Clin Res. 2010 Jan;1(1):29-32
pubmed: 21829779
Perspect Clin Res. 2013 Jul;4(3):181-5
pubmed: 24010060
Drug Saf. 2019 Dec;42(12):1393-1407
pubmed: 31446567
Drug Saf. 2015 Apr;38(4):373-82
pubmed: 25687792
Contemp Clin Trials. 2010 Jan;31(1):108-18
pubmed: 19900576
Drug Saf. 2010 Jul 1;33(7):e1-e23
pubmed: 20553053
Br J Clin Pharmacol. 2018 May;84(5):1072-1074
pubmed: 29512176
Pharmacoepidemiol Drug Saf. 2019 May;28(5):680-689
pubmed: 30767342
Birth Defects Res C Embryo Today. 2015 Jun;105(2):140-56
pubmed: 26043938
Methods Inf Med. 1974 Jul;13(3):169-78
pubmed: 4607443
Drug Saf. 2019 Dec;42(12):1487-1498
pubmed: 31559542